Microbiology

  1. Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation

    1. Keisuke Tabata
    2. Vibhu Prasad
    3. David Paul
    4. Ji-Young Lee
    5. Minh-Tu Pham
    6. Woan-Ing Twu
    7. Christopher J. Neufeldt
    8. Mirko Cortese
    9. Berati Cerikan
    10. Yannick Stahl
    11. Sebastian Joecks
    12. Cong Si Tran
    13. Christian Lüchtenborg
    14. Philip V’kovski
    15. Katrin Hörmann
    16. André C. Müller
    17. Carolin Zitzmann
    18. Uta Haselmann
    19. Jürgen Beneke
    20. Lars Kaderali
    21. Holger Erfle
    22. Volker Thiel
    23. Volker Lohmann
    24. Giulio Superti-Furga
    25. Britta Brügger
    26. Ralf Bartenschlager

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 has observably higher propensity to accept uracil as nucleotide substitution: Prevalence of amino acid substitutions and their predicted functional implications in circulating SARS-CoV-2 in India up to July, 2020

    1. Subrata Roy
    2. Himadri Nath
    3. Abinash Mallick
    4. Subhajit Biswas

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells

    1. Satish Sagar
    2. Ashok Kumar Rathinavel
    3. William E. Lutz
    4. Lucas R. Struble
    5. Surender Khurana
    6. Andy T Schnaubelt
    7. Nitish Kumar Mishra
    8. Chittibabu Guda
    9. Mara J. Broadhurst
    10. St. Patrick M. Reid
    11. Kenneth W. Bayles
    12. Gloria E. O. Borgstahl
    13. Prakash Radhakrishnan

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine

    1. Wakako Furuyama
    2. Kyle Shifflett
    3. Amanda N. Pinski
    4. Amanda J. Griffin
    5. Friederike Feldmann
    6. Atsushi Okumura
    7. Tylisha Gourdine
    8. Allen Jankeel
    9. Jamie Lovaglio
    10. Patrick W. Hanley
    11. Tina Thomas
    12. Chad S. Clancy
    13. Ilhem Messaoudi
    14. Kyle L. O’Donnell
    15. Andrea Marzi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Genomic diversity of SARS-CoV-2 can be accelerated by mutations in the nsp14 gene

    1. Kosuke Takada
    2. Mahoko Takahashi Ueda
    3. Shintaro Shichinohe
    4. Yurie Kida
    5. Chikako Ono
    6. Yoshiharu Matsuura
    7. Tokiko Watanabe
    8. So Nakagawa

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies

    1. Renhong Yan
    2. Ruoke Wang
    3. Bin Ju
    4. Jinfang Yu
    5. Yuanyuan Zhang
    6. Nan Liu
    7. Jia Wang
    8. Qi Zhang
    9. Peng Chen
    10. Bing Zhou
    11. Yaning Li
    12. Yaping Shen
    13. Shuyuan Zhang
    14. Long Tian
    15. Yingying Guo
    16. Lu Xia
    17. Xinyue Zhong
    18. Lin Cheng
    19. Xiangyang Ge
    20. Juanjuan Zhao
    21. Hong-Wei Wang
    22. Xinquan Wang
    23. Zheng Zhang
    24. Linqi Zhang
    25. Qiang Zhou

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Silicon Nitride Inactivates SARS-CoV-2 in vitro

    1. Caitlin W. Lehman
    2. Rafaela Flur
    3. Kylene Kehn-Hall
    4. Bryan J. McEntire
    5. B. Sonny Bal
    6. Ryan M. Bock

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Sequencing of SARS-CoV-2 genome using different nanopore chemistries

    1. Oscar González-Recio
    2. Mónica Gutiérrez-Rivas
    3. Ramón Peiró-Pastor
    4. Pilar Aguilera-Sepúlveda
    5. Cristina Cano-Gómez
    6. Miguel Ángel Jiménez-Clavero
    7. Jovita Fernández-Pinero

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. High titers of multiple antibody isotypes against the SARS-CoV-2 spike receptor-binding domain and nucleoprotein associate with better neutralization

    1. Maria G. Noval
    2. Maria E. Kaczmarek
    3. Akiko Koide
    4. Bruno A. Rodriguez-Rodriguez
    5. Ping Louie
    6. Takuya Tada
    7. Takamitsu Hattori
    8. Tatyana Panchenko
    9. Larizbeth A. Romero
    10. Kai Wen Teng
    11. Andrew Bazley
    12. Maren de Vries
    13. Marie I. Samanovic
    14. Jeffrey N. Weiser
    15. Ioannis Aifantis
    16. Joan Cangiarella
    17. Mark J. Mulligan
    18. Ludovic Desvignes
    19. Meike Dittmann
    20. Nathaniel R. Landau
    21. Maria Aguero-Rosenfeld
    22. Shohei Koide
    23. Kenneth A. Stapleford

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19

    1. Guillermo León
    2. María Herrera
    3. Mariángela Vargas
    4. Mauricio Arguedas
    5. Andrés Sánchez
    6. Álvaro Segura
    7. Aarón Gómez
    8. Gabriela Solano
    9. Eugenia Corrales-Aguilar
    10. Kenneth Risner
    11. Aarthi Narayanan
    12. Charles Bailey
    13. Mauren Villalta
    14. Andrés Hernández
    15. Adriana Sánchez
    16. Daniel Cordero
    17. Daniela Solano
    18. Gina Durán
    19. Eduardo Segura
    20. Maykel Cerdas
    21. Deibid Umaña
    22. Edwin Moscoso
    23. Ricardo Estrada
    24. Jairo Gutiérrez
    25. Marcos Méndez
    26. Ana Cecilia Castillo
    27. Laura Sánchez
    28. José María Gutiérrez
    29. Cecilia Díaz
    30. Alberto Alape

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 158 of 247 Next